{"count": 210, "results": [{"_id": "35873646", "pmid": 35873646, "pmcid": "PMC9303163", "title": "Simvastatin in the Treatment of Colorectal Cancer: A Review", "journal": "Evid Based Complement Alternat Med", "authors": ["Zang H", "Yang W", "Tian X"], "date": "2022-07-14T00:00:00Z", "doi": "10.1155/2022/3827933", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "3827933", "score": 50266.426, "text_hl": "The survival benefits are then analyzed by combining the re-positioned drugs with conventional @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ treatment methods. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ is a clinically commonly used @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ drug and exerts the effect of preventing @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@. ", "citations": {"NLM": "Zang H, Yang W, Tian X. Simvastatin in the Treatment of Colorectal Cancer: A Review Evid Based Complement Alternat Med. 2022;2022():3827933. PMID: 35873646", "BibTeX": "@article{35873646, title={Simvastatin in the Treatment of Colorectal Cancer: A Review}, author={Zang H and Yang W and Tian X}, journal={Evid Based Complement Alternat Med}, volume={2022}, pages={3827933}}"}}, {"_id": "32477689", "pmid": 32477689, "title": "A Population-Based Study of Simvastatin Drug-Drug Interactions in Cardiovascular Disease Patients.", "journal": "AMIA Jt Summits Transl Sci Proc", "authors": ["Wang J", "Chi CL", "St Peter WL", "Carlson A", "Loth M", "Pradhan PM", "Liang Y", "Chen WY", "Lenskaia T", "Robinson JG", "Adam TJ"], "date": "2020-05-30T00:00:00Z", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "664-673", "score": 50263.645, "text_hl": "A Population-Based Study of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Drug-Drug Interactions in @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@Cardiovascular Disease@@@ @SPECIES_9606 @@@Patients@@@.", "citations": {"NLM": "Wang J, Chi CL, St Peter WL, Carlson A, Loth M, Pradhan PM, Liang Y, Chen WY, Lenskaia T, Robinson JG, Adam TJ. A Population-Based Study of Simvastatin Drug-Drug Interactions in Cardiovascular Disease Patients. AMIA Jt Summits Transl Sci Proc. 2020;2020():664-673. PMID: 32477689", "BibTeX": "@article{32477689, title={A Population-Based Study of Simvastatin Drug-Drug Interactions in Cardiovascular Disease Patients.}, author={Wang J and Chi CL and St Peter WL and Carlson A and Loth M and Pradhan PM and Liang Y and Chen WY and Lenskaia T and Robinson JG and Adam TJ}, journal={AMIA Jt Summits Transl Sci Proc}, volume={2020}, pages={664-673}}"}}, {"_id": "37933122", "pmid": 37933122, "pmcid": "PMC10631324", "title": "Optimizing statin therapy for primary prevention of cardiovascular disease in type 2 diabetes mellitus patients: Exploring dose, class, and intensity", "journal": "Diab Vasc Dis Res", "authors": ["Yu JM", "Chen WM", "Shia BC", "Wu SY"], "date": "2023-11-01T00:00:00Z", "doi": "10.1177/14791641231214507", "meta_date_publication": "2023 Nov-Dec", "meta_volume": "20", "meta_issue": "6", "meta_pages": "14791641231214507", "score": 50261.207, "text_hl": "@CHEMICAL_pitavastatin @CHEMICAL_MESH:C108475 @@@Pitavastatin@@@ was found to have the lowest @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@CVD@@@ risk among the different classes of statins, followed by @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@fluvastatin@@@, and @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@. ", "citations": {"NLM": "Yu JM, Chen WM, Shia BC, Wu SY. Optimizing statin therapy for primary prevention of cardiovascular disease in type 2 diabetes mellitus patients: Exploring dose, class, and intensity Diab Vasc Dis Res. 2023 Nov-Dec;20(6):14791641231214507. PMID: 37933122", "BibTeX": "@article{37933122, title={Optimizing statin therapy for primary prevention of cardiovascular disease in type 2 diabetes mellitus patients: Exploring dose, class, and intensity}, author={Yu JM and Chen WM and Shia BC and Wu SY}, journal={Diab Vasc Dis Res}, volume={20}, number={6}, pages={14791641231214507}}"}}, {"_id": "32901573", "pmid": 32901573, "title": "Preparation and characterization of polypills containing aspirin and simvastatin using 3D printing technology for the prevention of cardiovascular diseases.", "journal": "Drug Dev Ind Pharm", "authors": ["Keikhosravi N", "Mirdamadian SZ", "Varshosaz J", "Taheri A"], "date": "2020-10-01T00:00:00Z", "doi": "10.1080/03639045.2020.1820034", "meta_date_publication": "2020 Oct", "meta_volume": "46", "meta_issue": "10", "meta_pages": "1665-1675", "score": 50258.38, "text_hl": "Preparation and characterization of polypills containing @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ using 3D printing technology for the prevention of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@.", "citations": {"NLM": "Keikhosravi N, Mirdamadian SZ, Varshosaz J, Taheri A. Preparation and characterization of polypills containing aspirin and simvastatin using 3D printing technology for the prevention of cardiovascular diseases. Drug Dev Ind Pharm. 2020 Oct;46(10):1665-1675. PMID: 32901573", "BibTeX": "@article{32901573, title={Preparation and characterization of polypills containing aspirin and simvastatin using 3D printing technology for the prevention of cardiovascular diseases.}, author={Keikhosravi N and Mirdamadian SZ and Varshosaz J and Taheri A}, journal={Drug Dev Ind Pharm}, volume={46}, number={10}, pages={1665-1675}}"}}, {"_id": "33751411", "pmid": 33751411, "pmcid": "PMC8390626", "title": "The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study", "journal": "J Gen Intern Med", "authors": ["Mueller AM", "Liakoni E", "Schneider C", "Burkard T", "Jick SS", "Krähenbühl S", "Meier CR", "Spoendlin J"], "date": "2021-09-01T00:00:00Z", "doi": "10.1007/s11606-021-06651-6", "meta_date_publication": "2021 Sep", "meta_volume": "36", "meta_issue": "9", "meta_pages": "2639-2647", "score": 50257.39, "text_hl": "@GENE_CYP3A4 @GENE_1576 @@@CYP3A4@@@-mediated interactions with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ have been described as a clinically relevant cause of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@muscular adverse events@@@. ", "citations": {"NLM": "Mueller AM, Liakoni E, Schneider C, Burkard T, Jick SS, Krähenbühl S, Meier CR, Spoendlin J. The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study J Gen Intern Med. 2021 Sep;36(9):2639-2647. PMID: 33751411", "BibTeX": "@article{33751411, title={The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study}, author={Mueller AM and Liakoni E and Schneider C and Burkard T and Jick SS and Krähenbühl S and Meier CR and Spoendlin J}, journal={J Gen Intern Med}, volume={36}, number={9}, pages={2639-2647}}"}}, {"_id": "32604984", "pmid": 32604984, "pmcid": "PMC7407207", "title": "The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells", "journal": "Pharmaceutics", "authors": ["Awan ZA", "Fahmy UA", "Badr-Eldin SM", "Ibrahim TS", "Asfour HZ", "Al-Rabia MW", "Alfarsi A", "Alhakamy NA", "Abdulaal WH", "Al Sadoun H", "Helmi N", "Noor AO", "Caraci F", "Almasri DM", "Caruso G"], "date": "2020-06-27T00:00:00Z", "doi": "10.3390/pharmaceutics12070597", "meta_date_publication": "2020 Jun 27", "meta_volume": "12", "meta_issue": "7", "meta_pages": "", "score": 50256.598, "text_hl": "...Statins, including @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SMV@@@), are commonly used for the control of hyperlipidaemia and have also proven therapeutic and preventative effects in @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@. ", "citations": {"NLM": "Awan ZA, Fahmy UA, Badr-Eldin SM, Ibrahim TS, Asfour HZ, Al-Rabia MW, Alfarsi A, Alhakamy NA, Abdulaal WH, Al Sadoun H, Helmi N, Noor AO, Caraci F, Almasri DM, Caruso G. The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells Pharmaceutics. 2020 Jun 27;12(7):. PMID: 32604984", "BibTeX": "@article{32604984, title={The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells}, author={Awan ZA and Fahmy UA and Badr-Eldin SM and Ibrahim TS and Asfour HZ and Al-Rabia MW and Alfarsi A and Alhakamy NA and Abdulaal WH and Al Sadoun H and Helmi N and Noor AO and Caraci F and Almasri DM and Caruso G}, journal={Pharmaceutics}, volume={12}, number={7}}"}}, {"_id": "33898117", "pmid": 33898117, "pmcid": "PMC8059484", "title": "Vitiligo: The Association With Metabolic Syndrome and the Role of Simvastatin as an Immunomodulator", "journal": "Cureus", "authors": ["Verma D", "Hussain K", "Namiq KS", "Firoz A", "Bouchama M", "Raza M", "Haris M", "Khan S"], "date": "2021-03-22T00:00:00Z", "doi": "10.7759/cureus.14029", "meta_date_publication": "2021 Mar 22", "meta_volume": "13", "meta_issue": "3", "meta_pages": "e14029", "score": 50256.47, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@, a potent statin drug used widely in @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@ and @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@, also possesses antioxidant and anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ properties by its action on @GENE_CD8A @GENE_925 @@@CD8@@@+ T cells. ", "citations": {"NLM": "Verma D, Hussain K, Namiq KS, Firoz A, Bouchama M, Raza M, Haris M, Khan S. Vitiligo: The Association With Metabolic Syndrome and the Role of Simvastatin as an Immunomodulator Cureus. 2021 Mar 22;13(3):e14029. PMID: 33898117", "BibTeX": "@article{33898117, title={Vitiligo: The Association With Metabolic Syndrome and the Role of Simvastatin as an Immunomodulator}, author={Verma D and Hussain K and Namiq KS and Firoz A and Bouchama M and Raza M and Haris M and Khan S}, journal={Cureus}, volume={13}, number={3}, pages={e14029}}"}}, {"_id": "36970211", "pmid": 36970211, "pmcid": "PMC10031343", "title": "Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms", "journal": "Acta Pharm Sin B", "authors": ["Yang Y", "Feng K", "Yuan L", "Liu Y", "Zhang M", "Guo K", "Yin Z", "Wang W", "Zhou S", "Sun H", "Yan K", "Yan X", "Wang X", "Duan Y", "Hu Y", "Han J"], "date": "2023-03-01T00:00:00Z", "doi": "10.1016/j.apsb.2022.11.012", "meta_date_publication": "2023 Mar", "meta_volume": "13", "meta_issue": "3", "meta_pages": "1036-1052", "score": 50254.668, "text_hl": "Compound @CHEMICAL_danshen_dripping_pill @CHEMICAL_MESH:C000604051 @@@Danshen Dripping Pill@@@ (CDDP) or CDDP combined with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ has been widely used to treat @SPECIES_9606 @@@patients@@@ with @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ and other @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@ in China. ", "citations": {"NLM": "Yang Y, Feng K, Yuan L, Liu Y, Zhang M, Guo K, Yin Z, Wang W, Zhou S, Sun H, Yan K, Yan X, Wang X, Duan Y, Hu Y, Han J. Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms Acta Pharm Sin B. 2023 Mar;13(3):1036-1052. PMID: 36970211", "BibTeX": "@article{36970211, title={Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms}, author={Yang Y and Feng K and Yuan L and Liu Y and Zhang M and Guo K and Yin Z and Wang W and Zhou S and Sun H and Yan K and Yan X and Wang X and Duan Y and Hu Y and Han J}, journal={Acta Pharm Sin B}, volume={13}, number={3}, pages={1036-1052}}"}}, {"_id": "36239913", "pmid": 36239913, "title": "Effectiveness of Simvastatin Versus Gemfibrozil for Primary Prevention of Cardiovascular Events: A Retrospective Cohort Study of 223,699 Primary Care Patients.", "journal": "Clin Drug Investig", "authors": ["Blais JE", "Ye X", "Wan EYF", "Wong WCW", "Wong ICK", "Tomlinson B", "Chan EW"], "date": "2022-11-01T00:00:00Z", "doi": "10.1007/s40261-022-01208-9", "meta_date_publication": "2022 Nov", "meta_volume": "42", "meta_issue": "11", "meta_pages": "987-997", "score": 50254.285, "text_hl": "Effectiveness of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Versus @CHEMICAL_Gemfibrozil @CHEMICAL_MESH:D015248 @@@Gemfibrozil@@@ for Primary Prevention of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@Cardiovascular Events@@@: A Retrospective Cohort Study of 223,699 Primary Care @SPECIES_9606 @@@Patients@@@.", "citations": {"NLM": "Blais JE, Ye X, Wan EYF, Wong WCW, Wong ICK, Tomlinson B, Chan EW. Effectiveness of Simvastatin Versus Gemfibrozil for Primary Prevention of Cardiovascular Events: A Retrospective Cohort Study of 223,699 Primary Care Patients. Clin Drug Investig. 2022 Nov;42(11):987-997. PMID: 36239913", "BibTeX": "@article{36239913, title={Effectiveness of Simvastatin Versus Gemfibrozil for Primary Prevention of Cardiovascular Events: A Retrospective Cohort Study of 223,699 Primary Care Patients.}, author={Blais JE and Ye X and Wan EYF and Wong WCW and Wong ICK and Tomlinson B and Chan EW}, journal={Clin Drug Investig}, volume={42}, number={11}, pages={987-997}}"}}, {"_id": "38621556", "pmid": 38621556, "title": "Solid self-emulsifying casein carrier for the improvement on the oral bioavailability of simvastatin.", "journal": "Int J Biol Macromol", "authors": ["Li H", "Sun H", "Zhao Y", "Wang S", "Zhao Y"], "date": "2024-04-13T00:00:00Z", "doi": "10.1016/j.ijbiomac.2024.131516", "meta_date_publication": "2024 Apr 13", "meta_volume": "", "meta_issue": "", "meta_pages": "131516", "score": 50253.637, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@) is a statin drug that can effectively control @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ and prevent @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@. ", "citations": {"NLM": "Li H, Sun H, Zhao Y, Wang S, Zhao Y. Solid self-emulsifying casein carrier for the improvement on the oral bioavailability of simvastatin. Int J Biol Macromol. 2024 Apr 13;():131516. PMID: 38621556", "BibTeX": "@article{38621556, title={Solid self-emulsifying casein carrier for the improvement on the oral bioavailability of simvastatin.}, author={Li H and Sun H and Zhao Y and Wang S and Zhao Y}, journal={Int J Biol Macromol}, pages={131516}}"}}]}